HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011

Clinical trial NCT06369831 · RECRUITING

Trial details

NCT number: NCT06369831
Sponsor: Abscint NV/SA
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Metastatic Solid Cancer

Start date: 2024-09-12
Primary completion: 2026-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.